In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused to grant Danish innovator Novo Nordisk ...

The highest priority should be adults with BMI over 35 or those with BMI over 30, who also have severe obesity-related ...

Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable ...

Shari Conditt, a US history teacher at Woodland High School in Woodland, WA, is named the first recipient of the award that ...

The authors conclude that early use of semaglutide may serve as an effective adjunctive strategy to mitigate the metabolic ...

Here are 5 things health experts say to expect after you stop taking GLP-1 drugs, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound).

Novo Nordisk is filing its supplemental new drug application (sNDA) for Wegovy 7.2 mg on the back of the phase 3b STEP UP ...

Novo Nordisk A/S remains a Strong Buy despite semaglutide's Alzheimer's trial miss. Click for NVO growth drivers, solid ...

Shares of Biogen rose 3% following news of Novo's Alzheimer's trial failure. Biogen and partner Eisai's Leqembi and rival Eli ...

Novo Nordisk has just released the topline findings from two eagerly anticipated phase 3 trials of its oral formulation of ...

Building on the momentum of its second acquisition in skin health this year, HMP Global will collaborate with SCALE founders to broaden clinical practice offerings and enter the high-growth aesthetics ...

These drugs must be started only after a full medical evaluation, used strictly under medical supervision and avoided entirely for cosmetic or event-driven weight loss ...